Please login to the form below

Not currently logged in
Email:
Password:

Pegasus strengthens its Pharma and Life Sciences division

Appoints three new team members to join its Northern base

Pegasus, an Ashfield company, has appointed a trio of new team members to join its pharma and life sciences division based in Macclesfield, UK.

Kesha Tansey joins the team from within Ashfield as an account director, a role that will see her lead integrated communications programmes.

She is joined by newly appointed senior account executive Trystan George, who moves from The Scott Partnership and Bill Johnson, who arrived from Langland as an account executive.

Jo Spadaccino, board director and head of pharma and life sciences, Pegasus, said: “Our Macclesfield office was only launched in the spring, but our unique proposition is already attracting fantastic candidates from around the north-west.

“I’m really looking forward to working with Kesha, Trystan and Billy, along with our existing Macclesfield team members, who continue shaping the direction of our new hub.”

Earlier this year, Pegasus scooped an award for ‘Excellence In Integrated Product/Brand Communications at the 2017 Communiqué awards.

5th September 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics